3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT), a cell proliferation positron emission tomography (PET) tracer, has been shown in numerous tumors to be more specific than 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) but less sensitive. We studied the capacity of a nontoxic concentration of 5-fluoro-2'-deoxyuridine (FdUrd), a thymidine synthesis inhibitor, to increase uptake of [(18)F]FLT in tumor xenografts
Use of radiolabeled nucleotides for tumor imaging is hampered by rapid in vivo degradation and low D...
Thymidylate synthase (EC 2.1.1.45) is a key enzyme for the de novo synthesis of DNA and as such a ta...
Non-invasive monitoring of tumor therapy response helps in developing personalized treatment strateg...
Purpose: 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT), a cell proliferation positron emission tomogra...
PURPOSE: 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT), a cell proliferation positron emission tom...
The positron emission tomography (PET) tracer 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT) has been p...
Positron emission tomography (PET) with [18F]-FDG is now firmly established as a clinical tool in on...
Positron emission tomography (PET) with {F-18}-FDG is nowfirmly established as a clinical tool in on...
AIM: 5-fluoro-2'-deoxyuridine (FdUrd) depletes the endogenous 5'-deoxythymidine triphosphate (dTTP) ...
Aim: 5-fluoro-2'-deoxyuridine (FdUrd) depletes the endogenous 5'-deoxythymidine triphosphate (dTTP) ...
In recent years, [F-18]-fluoro-3'-deoxy-3'-L-fluorothymidine ([F-18]FLT) has been developed as a pro...
In recent years, [F-18]-fluoro-3'-deoxy-3'-L-fluorothymidine ([F-18]FLT) has been developed as a pro...
The assessment of tissue-specific pharmacodynamics is desirable in the development of tumor-targeted...
<div><p>Background</p><p>Non-invasive imaging biomarkers of cellular proliferation hold great promis...
Background: Non-invasive imaging biomarkers of cellular proliferation hold great promise for quantif...
Use of radiolabeled nucleotides for tumor imaging is hampered by rapid in vivo degradation and low D...
Thymidylate synthase (EC 2.1.1.45) is a key enzyme for the de novo synthesis of DNA and as such a ta...
Non-invasive monitoring of tumor therapy response helps in developing personalized treatment strateg...
Purpose: 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT), a cell proliferation positron emission tomogra...
PURPOSE: 3'-deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT), a cell proliferation positron emission tom...
The positron emission tomography (PET) tracer 3'-deoxy-3'-[18F]fluorothymidine ([18F]FLT) has been p...
Positron emission tomography (PET) with [18F]-FDG is now firmly established as a clinical tool in on...
Positron emission tomography (PET) with {F-18}-FDG is nowfirmly established as a clinical tool in on...
AIM: 5-fluoro-2'-deoxyuridine (FdUrd) depletes the endogenous 5'-deoxythymidine triphosphate (dTTP) ...
Aim: 5-fluoro-2'-deoxyuridine (FdUrd) depletes the endogenous 5'-deoxythymidine triphosphate (dTTP) ...
In recent years, [F-18]-fluoro-3'-deoxy-3'-L-fluorothymidine ([F-18]FLT) has been developed as a pro...
In recent years, [F-18]-fluoro-3'-deoxy-3'-L-fluorothymidine ([F-18]FLT) has been developed as a pro...
The assessment of tissue-specific pharmacodynamics is desirable in the development of tumor-targeted...
<div><p>Background</p><p>Non-invasive imaging biomarkers of cellular proliferation hold great promis...
Background: Non-invasive imaging biomarkers of cellular proliferation hold great promise for quantif...
Use of radiolabeled nucleotides for tumor imaging is hampered by rapid in vivo degradation and low D...
Thymidylate synthase (EC 2.1.1.45) is a key enzyme for the de novo synthesis of DNA and as such a ta...
Non-invasive monitoring of tumor therapy response helps in developing personalized treatment strateg...